KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Other Non Operating Income (2016 - 2025)

Pacira BioSciences has reported Other Non Operating Income over the past 16 years, most recently at $5.5 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at $5.5 million for Q4 2025, down 30.28% from a year ago — trailing twelve months through Dec 2025 was -$983000.0 (down 113.08% YoY), and the annual figure for FY2025 was -$983000.0, down 113.08%.
  • Other Non Operating Income for Q4 2025 was $5.5 million at Pacira BioSciences, up from -$110000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for PCRX hit a ceiling of $7.8 million in Q4 2024 and a floor of -$16.9 million in Q1 2023.
  • Median Other Non Operating Income over the past 5 years was -$122000.0 (2024), compared with a mean of -$2.2 million.
  • Peak annual rise in Other Non Operating Income hit 2867.92% in 2025, while the deepest fall reached 27435.9% in 2025.
  • Pacira BioSciences' Other Non Operating Income stood at $2.6 million in 2021, then tumbled by 96.88% to $81000.0 in 2022, then plummeted by 20130.86% to -$16.2 million in 2023, then surged by 148.31% to $7.8 million in 2024, then tumbled by 30.28% to $5.5 million in 2025.
  • The last three reported values for Other Non Operating Income were $5.5 million (Q4 2025), -$110000.0 (Q3 2025), and -$10.7 million (Q2 2025) per Business Quant data.